PMC:3156114 / 10891-11171 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/3156114","sourcedb":"PMC","sourceid":"3156114","source_url":"https://www.ncbi.nlm.nih.gov/pmc/3156114","text":"Three models are also presented, with prevalences set at 5%, 20%, and 50%. Treatment failure, whether related to insufficient adherence to treatment or breakthrough infections during treatment to which the patient is adherent, is assumed to occur among 10% of patients (Table S3).","tracks":[]}